15. May 2025

Meet us at the SLAS Europe 2025 (20-22 May) in Hamburg!

The FASS Consortium is excited to take part in this year’s SLAS Europe conference

Poster Presentation

Catch Robert Harmel from EU-OPENSCREEN at our Poster to hear more about our work. Let’s connect and chat about FASS technology—whether you’re interested in a demo, want to collaborate, or have samples you’d like us to measure!

Innovation Spotlight

Our consortium partner Oryl Photonics has been selected for Innovation AveNEW, and is one of the finalists of the Ignite Award! Don’t miss the chance to meet Nathan Dupertuis and Orly Tarun from ORYL at the exhibition on May 21–22 and explore how solubility and aggregation measurements are being redefined!

Looking forward to seeing many of you in Hamburg!

9. May 2025

Our partner Oryl Photonics was selected for the innovation AveNEW at SLAS Europe!

Nathan Dupertuis (founder) comments::

I am looking forward to exhibit in the Innovation AveNEW corner at SLASEurope2025 in Hamburg, Germany organised by SLAS (Society for Laboratory Automation and Screening)! We will be just next our friends from PHABIOC.

Come find us in the exhibition on May 21st and 22nd to learn more about Oryl Photonics’ technology redefining solubility and aggregation measurement!

There will be a big announcement at the conference. Stay tuned!


The FASS – Fast and Accurate Solubility for Sustainability team will also be presenting a poster at the conference, check it out!

2. May 2025

Pioneering Business Development for FASS

Oryl Photonics and WP3

Bringing cutting-edge research to the pharmaceutical industry requires more than innovation—it demands a clear path to commercialization. In WP3, we focus on business development, ensuring that the FASS instrument not only meets scientific needs but is also market-ready.

Our efforts include:

  • Developing and validating a business plan for commercialization and go-to-market strategies.
  • Protecting intellectual property rights to safeguard innovations.
  • Meeting regulatory standards and establishing a robust supply chain for production.

Leading this effort is Oryl Photonics, an innovative technology company and EPFL spin-off dedicated to redefining solubility and aggregation measurements in the pharmaceutical industry. Using advanced nonlinear light scattering, Oryl is driving the development of the FASS instrument with contributions to:

  • Prototype development in WP1
  • Business development in WP3: Introducing the FASS instrumen to the market and establishing its value proposition for pharmaceutical and biotechnological companies.

By combining Oryl’s expertise with the WP3 team’s focus on strategy, we’re transforming the FASS instrument into a viable product that saves resources and advances drug research and development.

17. April 2025

Meet us in Berlin at the Helmholtz Drug Discovery Conference!

We’re excited to promote FASS at the Helmholtz Drug Discovery Conference between 28-30 April 2025 in Berlin!

FASS offers a disruptive solubility measurement for Drug Discovery – fast, accurate, and highly sensitive measurements designed for the needs of pharmaceutical and chemical industries.

Curious about how we’re redefining solubility measurements? Come find Robert Harmel and Yasemin Furtun Uçal from EU-OPENSCREEN at our poster and let`s chat!

We’re looking forward to connecting and discussing with fellow scientists, innovators, and collaborators at Hashtag#HDDC2025.